Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1Classical hematology 1

Conditions

Leukemia, Lymphocytic, Chronic, B-Cell 35Lymphoma 10Leukemia, B-Cell 10Leukemia 9Recurrence 8Lymphoma, Non-Hodgkin 7Lymphoma, Large B-Cell, Diffuse 6Lymphoma, Follicular 6Neoplasms 5Bronchiolitis Obliterans Syndrome 4Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Lymphoma, Mantle-Cell 3Lymphoma, B-Cell 2Hodgkin Disease 2Burkitt Lymphoma 2Waldenstrom Macroglobulinemia 1Thrombocytopenia 1Paraproteinemias 1Oncology Patients Receiving Chemotherapy 1Melanoma 1Lymphoma, B-Cell, Marginal Zone 1Lymphocytosis 1Lymphadenopathy 1Leukemia, Prolymphocytic 1Leukemia, Lymphoid 1Fever 1Fatigue 1Disease 1Agammaglobulinemia 1

Interventions

Therapeutics 20Exercise 16Yoga 15Modafinil 12Surveys and Questionnaires 11Psychiatric Rehabilitation 10Methylphenidate 7Acupuncture Therapy 7Therapeutic Touch 6Ultraviolet Therapy 5Educational Status 5Acceptance and Commitment Therapy 5Walking 4Sugars 4Physical Therapy Modalities 4Palliative Care 4Early Intervention, Educational 4Control Groups 4Behavior Therapy 4methyl hydroxyethyl cellulose 3Touch 3Exercise Therapy 3Epoetin Alfa 3Counseling 3Acupressure 3Standard of Care 2Sodium Chloride 2Resistance Training 2Qigong 2Music Therapy 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Fatigue × ofatumumab × Clear all
NCT01002755 2019-05-07

Lenalidomide and Ofatumumab in Treating Participants With Previously Treated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

M.D. Anderson Cancer Center

Phase 2 Completed
36 enrolled 7 charts
Classical hematologyLymphoidOther hematologic neoplasm

Lymphadenopathy, Agammaglobulinemia, Fatigue, Fever, Lymphocytosis, Paraproteinemias, Thrombocytopenia, Leukemia, Lymphocytic, Chronic, B-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡